You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Allergies and anaphylaxis

Pharmalgen for the treatment of bee and wasp venom allergy

  • Technology appraisal guidance
  • Reference number: TA246
  • Published:  22 February 2012
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Venom anaphylaxis - immunotherapy pharmalgen: consultee and commentator comments on the ACD

  • Venom anaphylaxis - immunotherapy pharmalgen: Royal College of Nursing

  • Venom anaphylaxis - immunotherapy pharmalgen: Royal College of Physicians

  • Venom anaphylaxis - immunotherapy pharmalgen: Royal College of Paediatrics and Child Health

  • Venom anaphylaxis - immunotherapy pharmalgen: Royal College of Pathologists

  • Venom anaphylaxis - immunotherapy pharmalgen: Department of Health

  • Venom anaphylaxis - immunotherapy pharmalgen: Healthcare Improvement Scotland


This page was last updated: 12 December 2011

Back to top